ClinicalTrials.govpublic full text
Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome
hypertension with metabolic syndrome, hypertension, metabolic syndrome, dual combination therapy, triple combination therapy, aliskiren, direct renin inhibitor, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 902475
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.